Maximilian Nitschké is a Principle Scientific Researcher at Genentech. Maximilian has studied biology at the LMU in Munich and received his PhD from the Institute of Pharmaceutical Sciences at the ETH, Switzerland, in 2012. Maximilian moved to the University of California, San Francisco for his postdoctoral studies before joining Genentech in 2017. His main research interest is cancer immunology, with a focus on myeloid cell biology. At Genentech he is involved in investigating fundamental questions about immune cell regulation and development and their potential translational applications.